Quality improvement is central to achieving high-value care. Learn how we collaborate with all industry stakeholders to identify and bridge measurement gaps and advance patient care.
Listen to Debbie Lucas discuss how quality measurement can lead to improvements in the quality of care and the impact on providers.
The use of quality and performance measures in public reporting, value-based purchasing, and alternative payment models is altering clinical practice by providing incentives to improve quality measures performance and provide high-value care. Debbie Lucas helps many stakeholders seek to understand these measures, assess their business impacts, and use the information to guide decision-making.
In the Calendar Year (CY) 2015 End Stage Renal Disease (ESRD) Prospective Payment System (PPS) proposed rule released on July 2, CMS proposes a 2015 base per treatment rate of $239.33, up slightly from $239.02 in CY 2014.
Avalere’s experts will be presenting several posters at AcademyHealth’s Annual Research Meeting in San Diego.
On Feb. 21, CMS enhanced the Physician Compare website to include the addition of quality measures to indicate the performance achieved on a set number of specific metrics.